Politics Chuck Grassley

  • WASHINGTON— Sonny Perdue, a farmer's son who built businesses in grain trading and trucking before becoming the first Republican governor of Georgia since Reconstruction, is President-elect Donald Trump's choice to lead the Agriculture Department, The Associated Press has learned. Perdue, 70, who comes from the small city of Bonaire in rural central...

  • WASHINGTON— Donald Trump's pick to lead the Treasury Department, Stephen Mnuchin, built his reputation and his fortune as a savvy Wall Street investor. Mnuchin, who assembled a group to buy the bank from the government, renamed it OneWest and turned it around, selling it for a handsome profit to CIT Group Inc. in 2014.. But critics have cited the bank's foreclosure...

  • Mylan has come under fire for raising the price of a pair of EpiPens to $600 from $100 in 2008 and listing it with Medicaid as a generic product even though it is listed with the U.S. Food and Drug Administration as a branded product. Companies pay smaller rebates to Medicaid for generics. Officials at the Justice Department and the Centers for Medicare and...

  • BEIJING, Nov 17- A powerful U.S. senator said he is concerned that state-owned ChemChina, which is buying Swiss crop protection and seed group Syngenta for $43 billion, could use U.S. sovereign immunity laws to shield itself from claims in U.S. courts. The acquisition by China National Chemical Corp of Syngenta, the largest global investment by a Chinese company,...

  • Sens. Pat Toomey, R-Pa.

    Republicans won key Senate races as Democrats have only been able to flip two seats in Illinois and New Hampshire.

  • Oct 19- In the latest apparent spoof on a U.S. securities regulator's online filing system, a Chicago- area artist with a fondness for inspirational quotes claimed to have acquired about $88 billion worth of Bank of America Corp shares on Wednesday. The filing did not appear to influence the stock price of the second-largest U.S. bank, which joins companies...

  • WASHINGTON D.C./ NEW YORK, Sept 14- As the global agricultural sector races to consolidate, Bayer AG's $66 billion all-cash deal to acquire Monsanto Co will test growing political and consumer unease in the United States and abroad over the future of food production. Monsanto and Bayer "have chosen to do a deal in the year of merging dangerously," said David Balto, a...

  • By Diane Bartz and Greg Roumeliotis. WASHINGTON D.C./ NEW YORK, Sept 14- As the global agricultural sector races to consolidate, Bayer AG's $66 billion all-cash deal to acquire Monsanto Co will test growing political and consumer unease in the United States and abroad over the future of food production. Monsanto and Bayer "have chosen to do a deal in the year of...

  • "We requested a meeting with the FDA," Sigurdur Olafsson, Teva's head of global generic medicines, said in a webcast overview of the company's generics medicines business. He said Teva did not get a response, but after "the media attention in the last two weeks, the FDA has come back to us and we will have a meeting very, very quickly." Given the recent "political noise on...

  • "We requested a meeting with the FDA," Sigurdur Olafsson, Teva's head of global generic medicines, said in a webcast overview of the company's generics medicines business. He said Teva did not get a response, but after "the media attention in the last two weeks, the FDA has come back to us and we will have a meeting very, very quickly." Given the recent "political noise on...

  • WASHINGTON, Sept 9- The chairman of the U.S. Senate Judiciary Committee probing Mylan NV's EpiPen price hike on Friday said its response to his query was "incomplete," and called on the drugmaker to give more details over how much government health insurance programs pay for the allergy treatment. "It's an incomplete response and wouldn't satisfy my constituents...

  • The list price of the drug will remain the same, but the company said it would increase the maximum copay assistance program to $300 from $100 for patients who pay for the 2- pak in cash or who are covered by a commercial health insurer. The price of EpiPen has skyrocketed to $600 from $100 since it was acquired by Mylan in 2007.. Ronny Gal, an analyst with Bernstein,...

  • Sen. Charles Grassley

    There needs to be more transparency in drug pricing, and Mylan still has a lot of questions to answer, Sen. Charles Grassley said Thursday.

  • The list price of the drug will remain the same, but the company said it would increase the maximum copay assistance program to $300 from $100 for patients who pay for the 2- pak in cash or who are covered by a commercial health insurer. The price of EpiPen has skyrocketed to $600 from $100 since it was acquired by Mylan in 2007.. Ronny Gal, an analyst with Bernstein,...

  • Aug 25- Mylan NV said on Thursday it would reduce the out-of-pocket cost of its severe allergy treatment EpiPen through a discount program, a day after Democratic Presidential candidate Hillary Clinton joined lawmakers in criticizing the drug's high price. The price of the product, acquired in 2007, has skyrocketed to $600 from $100 in 2008.

  • Aug 25- Mylan NV said on Thursday it would reduce the out-of-pocket cost of its severe allergy treatment EpiPen through a discount program, a day after Democratic Presidential candidate Hillary Clinton joined lawmakers in criticizing the drug's high price. The company, which did not lower the drug's list price, said it would reduce the patient cost of EpiPen...

  • WASHINGTON, Aug 24- Democratic presidential candidate Hillary Clinton called on pharmaceutical company Mylan NV to voluntarily drop the price of its severe allergy treatment drug EpiPen, which has increased in price by more than 400 percent in the past decade. Mylan spokeswoman Nina Devlin did not respond to inquiries about Clinton's criticism of the...

  • WASHINGTON, Aug 24- Democratic presidential candidate Hillary Clinton called on pharmaceutical company Mylan NV to voluntarily drop the price of its severe allergy treatment drug EpiPen, which has increased in price by more than 400 percent in the past decade. Mylan spokeswoman Nina Devlin did not respond to inquiries about Clinton's criticism of the...

  • WASHINGTON, Aug 24- Democratic presidential candidate Hillary Clinton called on pharmaceutical company Mylan NV to voluntarily drop the price of its severe allergy treatment drug EpiPen, which has increased in price by more than 400 percent in the past decade. The White House took a more cautious tone in criticizing rising drug costs, refusing to comment on...

  • A child receives treatment with an EpiPen.

    Two senior lawmakers on the U.S. Senate's Judiciary Committee pushed for information regarding sharp price increases for EpiPens.